|
Journal of Bone and Joint Surgery - British Volume, Vol 89-B, Issue 6,
742-745.
doi: 10.1302/0301-620X.89B6.18680 Copyright © 2007 by British Editorial Society of Bone and Joint Surgery Fracture of the hydroxyapatite-ceramic-coated JRI-Furlong femoral componentBODY MASS INDEX AND IMPLICATIONS FOR SELECTION OF THE IMPLANTP. Harvie, BEng, MRCS (Eng), Specialist Registrar1; M. Haroon, FRCS, Associate Specialist2; N. Henderson, MA, FRCS, Consultant Trauma and Orthopaedic Surgeon2; and M. El-Guindi, FRCS, Consultant Trauma and Orthopaedic Surgeon2
1 Nuffield Department of Orthopaedic Surgery, University of Oxford, Nuffield Orthopaedic Centre, Windmill Road, Headington, Oxford OX3 7LD, UK. Correspondence should be sent to Dr P. Harvie; e-mail: harvie1{at}tiscali.co.uk
We describe three cases of fracture of the titanium JRI-Furlong hydroxyapatite-ceramic (HAC)-coated femoral component. We have examined previous case reports of failure of this stem and conclude that fracture may occur in two places, namely at the neck-shoulder junction and at the conical-distal cylindrical junction. These breakages are the result of fatigue in a metallurgically-proven normal femoral component. All the cases of failure of the femoral component have occurred in patients with a body mass index of more than 25 in whom a small component, either size 9 or 10, had been used. In patients with a body mass index above normal size 9 components should be avoided and the femoral canal should be reamed sufficiently to accept a large femoral component to ensure that there is adequate metaphyseal fixation.
|
|


